Nova Eye Medical Limited
ELXMF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$9,059 | -$8,790 | -$15,293 | -$7,496 |
| Dep. & Amort. | $2,262 | $2,989 | $2,297 | $1,811 |
| Deferred Tax | $0 | $0 | -$4,507 | -$2,111 |
| Stock-Based Comp. | $89 | $0 | $178 | $203 |
| Change in WC | $690 | -$2,057 | $191 | $2,389 |
| Other Non-Cash | -$132 | $1 | $10,413 | $521 |
| Operating Cash Flow | -$6,150 | -$7,857 | -$6,721 | -$4,683 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$298 | -$211 | -$800 | -$5,591 |
| Net Acquisitions | $0 | $0 | $0 | $1,015 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$66 | -$114 | $0 | $0 |
| Investing Cash Flow | -$364 | -$325 | -$800 | -$4,576 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$613 | -$518 | -$653 | -$402 |
| Stock Issued | $0 | $7,430 | $7,470 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $6,169 | $0 | $0 | $0 |
| Financing Cash Flow | $5,556 | $6,912 | $6,817 | -$402 |
| Forex Effect | -$138 | $2 | $123 | -$140 |
| Net Chg. in Cash | -$1,096 | -$1,268 | -$581 | -$9,801 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $6,151 | $7,419 | $8,000 | $17,801 |
| End Cash | $5,055 | $6,151 | $7,419 | $8,000 |
| Free Cash Flow | -$6,448 | -$8,306 | -$7,521 | -$10,274 |